Prostate cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with high-risk prostate cancer 2) Patients undergoing radiotherapy and hyperthermia 3) Patients who are 20 years of age or older at the time of enrollment 4) Patients with an ECOG Performance Status (PS) of 0 to 2 5) Patients expected to survive more than 3 months
Exclusion criteria
Exclusion criteria: 1) Patients with multiple cancers (simultaneous multiple cancers or iatrogenic multiple cancers with a disease-free interval of 5 years or less).However, intraepithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer are not included in overlapping cancers. 2) Patients who have a history of irradiation (re-irradiation) at the same site as the current irradiation. 3) Patients who will be treated with three-dimensional source body irradiation 4) Patients who will not receive concomitant endocrine therapy 5) Patients who are scheduled to receive concomitant small source radiation therapy 6) Patients who are judged by the principal investigator to be inappropriate for enrollment in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year biochemical recurrence-free survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 3/5/8-year overall/cause-specific /clinical recurrence-free survival rate, Adverse event rate, Transitions in the IPSS and QOL scores | — |
Countries
Japan
Contacts
Aichi Medical University Hospital Radiology